Berger, Jeffrey S.

Ticagrelor versus Clopidogrel in Symptomatic Peripheral Artery Disease

Hiatt, W. R., Fowkes, F. G. R., Heizer, G., Berger, J. S., Baumgartner, I., Held, P., Katona, B. G., Mahaffey, K. W., Norgren, L., Jones, W. S., et al. (2017) · New England Journal of Medicine

Antiplatelet Therapy and Cardiovascular DiseasesPeripheral Artery Disease Management

Cited by 636

Management of coronary disease in patients with advanced kidney disease

Bangalore, S., Maron, D. J., O’Brien, S. M., Fleg, J. L., Kretov, E. I., Briguori, C., Kaul, U., Reynolds, H. R., Mazurek, T., Sidhu, M. S., et al. (2020) · New England Journal of Medicine

Coronary Interventions and DiagnosticsCardiac Imaging and Diagnostics

Cited by 499

Representation of Women in Randomized Clinical Trials of Cardiovascular Disease Prevention

Melloni, C., Berger, J. S., Wang, T. Y., Gunes, F., Stebbins, A., Pieper, K. S., Dolor, R. J., Douglas, P. S., Mark, D. B., & Newby, L. K. (2010) · Circulation: Cardiovascular Quality and Outcomes

Sex and Gender in HealthcareDiversity and Career in Medicine

Cited by 455

Neural correlates of cognitive efficiency

Rypma, B., Berger, J. S., Prabhakaran, V., Martin Bly, B., Kimberg, D. Y., Biswal, B. B., & D'Esposito, M. (2006) · NeuroImage

Neural and Behavioral Psychology StudiesCognitive Abilities and Testing

Cited by 334

Screening for cardiovascular risk in asymptomatic patients

Berger, J. S., Jordan, C. O., Lloyd-Jones, D., & Blumenthal, R. S. (2010) · Journal of the American College of Cardiology

Health Promotion and Cardiovascular PreventionLipoproteins and Cardiovascular Health

Cited by 238

Effects of Antibiotic Therapy on Outcomes of Patients With Coronary Artery Disease: A Meta-analysis of Randomized Controlled Trials

Andraws, R., Berger, J. S., & Brown, D. L. (2005) · JAMA

Atherosclerosis and Cardiovascular DiseasesLipoproteins and Cardiovascular Health

Cited by 235

Effect of a Home-Based Exercise Intervention of Wearable Technology and Telephone Coaching on Walking Performance in Peripheral Artery Disease: The HONOR Randomized Clinical Trial

McDermott, M. M., Spring, B., Berger, J. S., Treat-Jacobson, D., Conte, M. S., Creager, M. A., Criqui, M. H., Ferrucci, L., Gornik, H. L., Guralnik, J. M., et al. (2018) · JAMA

Peripheral Artery Disease ManagementCardiovascular and exercise physiology

Cited by 211

Primary Prevention of Cardiovascular Disease in Diabetes Mellitus

Newman, J. D., Schwartzbard, A. Z., Weintraub, H. S., Goldberg, I. J., & Berger, J. S. (2017) · Journal of the American College of Cardiology

Diabetes, Cardiovascular Risks, and LipoproteinsDiabetes Treatment and Management

Cited by 205

Underuse of Prevention and Lifestyle Counseling in Patients With Peripheral Artery Disease

Berger, J. S., & Ladapo, J. A. (2017) · Journal of the American College of Cardiology

Peripheral Artery Disease ManagementHealth Promotion and Cardiovascular Prevention

Cited by 183

Reproductive Risk Factors and Coronary Heart Disease in the Women’s Health Initiative Observational Study

Parikh, N. I., Jeppson, R. P., Berger, J. S., Eaton, C. B., Kroenke, C. H., LeBlanc, E. S., Lewis, C. E., Loucks, E. B., Parker, D. R., Rillamas-Sun, E., et al. (2016) · Circulation

Menopause: Health Impacts and TreatmentsCardiovascular Health and Risk Factors

Cited by 134

Physicians’ Dietary Knowledge, Attitudes, and Counseling Practices: The Experience of a Single Health Care Center at Changing the Landscape for Dietary Education

Harkin, N., Johnston, E., Mathews, T., Guo, Y., Schwartzbard, A., Berger, J., & Gianos, E. (2019) · American Journal of Lifestyle Medicine

Dietetics, Nutrition, and EducationInnovations in Medical Education

Cited by 83

The Neutrophil to Lymphocyte Ratio Is Associated With the Risk of Subsequent Dementia in the Framingham Heart Study

Ramos-Cejudo, J., Johnson, A. D., Beiser, A., Seshadri, S., Salinas, J., Berger, J. S., Fillmore, N. R., Do, N., Zheng, C., Kovbasyuk, Z., et al. (2021) · Frontiers in Aging Neuroscience

Dementia and Cognitive Impairment ResearchInflammatory Biomarkers in Disease Prognosis

Cited by 49

Design and rationale for the Effects of Ticagrelor and Clopidogrel in Patients with Peripheral Artery Disease (EUCLID) trial

Berger, J. S., Katona, B. G., Jones, W. S., Patel, M. R., Norgren, L., Baumgartner, I., Blomster, J., Mahaffey, K. W., Held, P., Millegård, M., et al. (2016) · American Heart Journal

Antiplatelet Therapy and Cardiovascular DiseasesPeripheral Artery Disease Management

Cited by 47

Safety and effectiveness of rivaroxaban and apixaban in patients with venous thromboembolism: a nationwide study

Sindet-Pedersen, C., Staerk, L., Pallisgaard, J. L., Gerds, T. A., Berger, J. S., Torp-Pedersen, C., Gislason, G. H., & Olesen, J. B. (2018) · European Heart Journal - Cardiovascular Pharmacotherapy

Venous Thromboembolism Diagnosis and ManagementAtrial Fibrillation Management and Outcomes

Cited by 30